Related Experiment Video
Updated: Jun 23, 2026
08:47
Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
Published on: December 16, 2022
Metabolic modulation and cellular therapy of cardiac dysfunction and failure
Diana Revenco1, James P Morgan
1Division of Cardiovascular Medicine, Caritas St. Elizabeth's Medical Center, Boston, MA 02135, USA.
Journal of Cellular and Molecular Medicine
|April 23, 2009
Summary
Emerging therapies for advanced heart failure include metabolic modulation to improve heart energy use and cellular therapy for cardiac regeneration. These novel strategies offer new hope for patients with progressive heart failure.
Area of Science:
- Cardiology
- Regenerative Medicine
- Metabolic Research
Background:
- Heart failure prevalence is increasing due to population aging.
- Current treatments for heart failure offer symptomatic relief but do not halt disease progression.
- Advanced heart failure affects a growing number of patients, necessitating novel therapeutic approaches.
Purpose of the Study:
- To review emerging therapeutic strategies for advanced heart failure.
- To discuss metabolic modulation for optimizing myocardial energy utilization.
- To explore cellular therapy for achieving cardiac regeneration.
Main Methods:
- Review of experimental data supporting metabolic modulation and cellular therapy.
- Examination of pharmacological agents for metabolic modulation.
- Assessment of the clinical application of cellular therapy.
Main Results:
- Metabolic modulation shifts myocardial substrate utilization from free fatty acids to glucose.
- Cellular therapy aims to achieve true cardiac regeneration.
- Experimental data support both strategies for heart failure treatment.
Conclusions:
- Metabolic modulation and cellular therapy represent promising new avenues for treating advanced heart failure.
- These emerging therapies target fundamental aspects of heart failure pathophysiology.
- Further research and clinical trials are needed to fully realize the potential of these strategies.
More Related Videos
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
11:51Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
Published on: March 1, 2016
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:26Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
01:19Regulation of Metabolism
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...